Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 50268-722

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 50268-722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 (722 15)

This seems to be the packaging of Ranolazine tablets, with 50 tablets per package. The tablets are extended-release and are to be taken orally. The provided text also includes the NDC number (50268.722:15) and dosage information for 50 tablets. The instructions warn against crushing or chewing the tablets. It also provides information on storage conditions of the tablets. There is a manufacturing company mentioned, RRE J, but no further details about it.*

FDA Label Image

30 (723 13)

FDA Label Image

Ranolazine-structure (Ranolazine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.